Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation
| author | |
| created | [InstanceEdit:9649010] Rothfels, Karen, 2019-06-10 |
| dbId | 9649006 |
| displayName | Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation |
| journal | J Cancer |
| pages | 3394-3399 |
| pubMedIdentifier | 30271501 |
| schemaClass | LiteratureReference |
| title | Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation |
| url | http://www.ncbi.nlm.nih.gov/pubmed/30271501 |
| volume | 9 |
| year | 2018 |
Referrals
| (literatureReference) | |
| (author) |
© 2026 Reactome
